Barry Lederman serves as the Chief Financial Officer (CFO) at Worldwide Clinical Trials, a leading Global Clinical Research Organization (CRO) based in the Raleigh-Durham area of North Carolina. With a robust background in finance and a proven track record of executing multiple home-run exit transactions,...
Barry Lederman serves as the Chief Financial Officer (CFO) at Worldwide Clinical Trials, a leading Global Clinical Research Organization (CRO) based in the Raleigh-Durham area of North Carolina. With a robust background in finance and a proven track record of executing multiple home-run exit transactions, Barry has established himself as a pivotal figure in the private equity landscape. His recent success in navigating the complex transition from one private equity firm to another in December 2023 underscores his strategic acumen and ability to drive value in high-stakes environments.
In his role, Barry leverages his extensive international and operational experience to foster growth and profitability. He partners closely with the CEO and collaborates with executive teams to challenge conventional thinking, ensuring that financial strategies align with the organization’s short and long-term objectives. His expertise in financial modeling, budgeting, and financial planning enables him to build a world-class finance function that supports the company's mission to deliver innovative clinical solutions.
Barry's leadership extends beyond traditional finance roles; he actively engages in risk management and policy development, ensuring that the organization adheres to best practices while navigating the complexities of the clinical research industry. His background in mergers and acquisitions further enhances his capability to identify and capitalize on strategic opportunities, driving operational efficiency through lean manufacturing principles. As a forward-thinking CFO, Barry Lederman continues to play a crucial role in shaping the future of Worldwide Clinical Trials, positioning the organization for sustained success in a competitive market.
